Arginine

plasminogen ; Homo sapiens







45 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34768908 Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy. 2021 Oct 25 3
2 27797450 S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin. 2016 Dec 1
3 25937317 Exploitation of plasmin(ogen) by bacterial pathogens of veterinary significance. 2015 Jul 9 1
4 22079445 Liporetro-D-peptides - a novel class of highly selective thrombin inhibitors. 2012 Apr 1
5 22610100 Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor. 2012 Jul 20 2
6 17989726 Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. 2008 May 2
7 17189254 Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation. 2007 Feb 23 7
8 16708124 Monitoring of plasmin and plasminogen activator activity in blood of patients under fibrinolytic treatment by reteplase. 2006 Apr 3
9 16015416 Functional determination of plasmin in arginine-stabilized plasma. 2005 Jul 7
10 16087677 Plasmin- and thrombin-accelerated shedding of syndecan-4 ectodomain generates cleavage sites at Lys(114)-Arg(115) and Lys(129)-Val(130) bonds. 2005 Oct 14 1
11 14567541 Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction. 2003 Jun 1
12 12022872 Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor. 2002 May 28 1
13 12924019 [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin]. 2002 Nov-Dec 3
14 11369771 Streptokinase triggers conformational activation of plasminogen through specific interactions of the amino-terminal sequence and stabilizes the active zymogen conformation. 2001 Jul 13 1
15 11724583 Domain interactions between streptokinase and human plasminogen. 2001 Dec 4 2
16 10873770 The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. 2000 Jul 5 2
17 10873836 Negative selectivity and the evolution of protease cascades: the specificity of plasmin for peptide and protein substrates. 2000 Jun 1
18 10896248 Proteolytic modulation of thrombopoietin activity: comparison of thrombin, plasmin, and urokinase. 2000 Jun 1
19 9923600 The extracellular processing of HIV-1 envelope glycoprotein gp160 by human plasmin. 1999 Jan 8 1
20 10496984 Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. 1999 Oct 1 2
21 10556566 Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site. 1999 Sep 14 1
22 10585738 Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection. 1999 Dec 1 1
23 9572854 Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex. 1998 May 5 1
24 9798984 Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis. 1998 Oct 1
25 9169591 Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. 1997 May 1 1
26 9202057 Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. 1997 Jul 1 1
27 9253802 Effect of L-arginine on in vitro plasmin-generation and fibrinogenolysis. 1997 Jul 1 4
28 9132167 Site-directed mutagenesis at 134/135 in human growth hormone alters its in vivo half-life in the rat. 1996 Apr 1
29 8356923 Cytokine regulation of endothelial cell extracellular proteolysis. 1993 1
30 1318546 A structural assessment of the apo[a] protein of human lipoprotein[a]. 1992 Feb 1
31 1382726 Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation. 1992 Jun 1
32 1387746 [The effect of arginine on hydrolysis of fibrinogen by plasmin and mini-plasmin]. 1992 Jan-Feb 3
33 1531588 Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin. 1992 Feb 1 1
34 1828038 Generation of interleukin-8 by plasmin from AVLPR-interleukin-8, the human fibroblast-derived neutrophil chemotactic factor. 1991 May 6 3
35 2551057 Plasmin's peptide-binding specificity: characterization of ligand sites in alpha 2-antiplasmin. 1989 Jun 15 1
36 2768221 X-ray analysis of a thrombin inhibitor-trypsin complex. 1989 Jun 1
37 2968979 A predicted tertiary structure of a thrombin inhibitor-trypsin complex explains the mechanisms of the selective inhibition of thrombin, factor Xa, plasmin, and trypsin. 1988 Mar 1
38 2954262 Similarity and dissimilarity in the stereogeometry of the active sites of thrombin, trypsin, plasmin and glandular kallikrein. 1987 Mar 1 1
39 3315613 Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex. 1987 1
40 2932824 [Lysine- and arginyl-binding sites of plasminogen domains]. 1985 Sep-Oct 1
41 2933077 Catalytic properties of human Lys77-plasmin. A comparative steady-state and pre-steady-state study. 1985 Nov 29 3
42 6197164 Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues. 1984 Jan 1
43 6448971 ["In vitro" protaminase activity of human plasma and serum and the human carboxypeptidase N (author's transl)]. 1980 Oct 3
44 6449829 Activation of factor XII in plasma from rats pretreated with tranexamic acid. Inhibition of a plasmin-induced loss of the functional activity of high molecular weight kininogen. 1980 Sep 1
45 4229624 [Activity of plasmin and streptokinase-activator on substituted arginine and lysine esters]. 1966 Jul 31 1